References
- Reeves A, Swenson R. Disorders of the Nervous System. 3rd ed. Gardena, CA: Imperial Company Printers; 1995
- Soule B, Simone N. Hypokalemic periodic paralysis: a case report and review of the literature. Cases J 2008;1:256
- Layzer RB. Neuromuscular manifestation of endocrine disease. In Becker KL, ed. Principles and Practice of Endocrinology and Metabolism. Philadelphia, PA: JB Lippincott; 1990. 1536
- Jones PN. American Indian mtDNA, Y Chromosome Genetic Data, and the Peopling of North America. Boulder, CO: Bauu Institute; 2004
- Kung A. Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab 2006;91:2490–5
- Loh KC, Pinheiro L, Ng KS. Thyrotoxic period paralysis complicated by near-fatal ventricular arrhythmias. Singapore Med J 2005;46:88–9
- Lin Y, Wu CW, Chen HC, et al. Surgical treatment for thyrotoxic hypokalemic periodic paralysis: case report. World J Surg Oncol 2012;10:21
- Birkhahn RH, Gaeta TJ, Melniker L. Thyrotoxic periodic paralysis and intravenous propranolol in the emergency setting. J Emerg Med 2000;18:199–202
- Hsieh MJ, Lyu RK, Chang WN, et al. Hypokalemic thyrotoxic periodic paralysis: clinical characteristics and predictors of recurrent paralytic attacks. Eur J Neurol 2008;15:559–64
- Silva MR, et al. Thyrotoxic hypokalemic periodic paralysis, an endocrine emergency: clinical and genetic features in 25 patients. Arq Bras Endocrinol Metab 2004;48:196–215